Nephrotoxicity related to new therapeutic compounds

Renal Failure

Volumn 27, Issue 3, 2005, Pages 329-333

  Szeto, Cheuk Chun ^a   Chow, Kai Ming ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Acute renal failure; NSAID; Pamidronate

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; ACYCLIC NUCLEOSIDE; ADEFOVIR DIPIVOXIL; AMPICILLIN; ANTIVIRUS AGENT; ASCORBIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CEFALEXIN; CELECOXIB; CIDOFOVIR; CIPROFLOXACIN; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FOSCARNET; HETASTARCH; IMMUNOGLOBULIN; INDINAVIR; INDOMETACIN; METHOTREXATE; NAPROXEN; NEW DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PAMIDRONIC ACID; PHOSPHONIC ACID DERIVATIVE; PLASMA SUBSTITUTE; PRIMIDONE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; ROFECOXIB; STABILIZING AGENT; SUCROSE; SULFONAMIDE; TENOFOVIR; TRIAMTERENE; XYLITOL;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ANALGESIC NEPHROPATHY; ANKLE EDEMA; ARTICLE; CRYSTALLURIA; DRUG MEGADOSE; FANCONI RENOTUBULAR SYNDROME; FOCAL GLOMERULOSCLEROSIS; GLUCOSURIA; GRANULOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY TUBULE DISORDER; KIDNEY TUMOR; NEPHROLITHIASIS; NEPHROSIS; NEPHROTOXICITY; PRIORITY JOURNAL; SIDE EFFECT; SODIUM RETENTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DIPHOSPHONATES; HIV PROTEASE INHIBITORS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INCIDENCE; KIDNEY DISEASES;

EID: 20044363131     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-200056595     Document Type: Article

References (22)

1. Thadhani, R.; Pascual, M.; Bonventre, J.V. Acute renal failure. N. Engl. J. Med. 1996, 334, 1448-1460.
2. Khan, K.N.; Paulson, S.K.; Verburg, K.M.; Lefkowith, J.B.; Maziasz, T.J. Pharmacology of cyclooxygenase-2 inhibition in the kidney. Kidney Int. 2002, 61, 1210-1219.
3. Rossat, J.; Maillard, M.; Nussberger, J.; Brunner, H.R.; Burnier, M. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin. Pharmacol. Ther. 1999, 66, 76-84.
4. Whelton, A.; Schulman, G.; Wallemark, C.; Drower, E.J.; Isakson, P.C.; Verburg, K.M.; Geis, G.S. Effects of celecoxib and naproxen on renal function in the elderly. Arch. Intern. Med. 2000, 160, 1465-1470.
5. Whelton, A.; Brater, D.C.; Sica, D.A. Effects of celecoxib and naproxen on renal function in chronic renal insufficiency patients [abstract]. J. Am. Soc. Nephrol. 1999, 10, 92A.
6. Catella-Lawson, F.; McAdam, B.; Morrison, B.W.; Kapoor, S.; Kujubu, D.; Antes, L.; Lasseter, K.C.; Quan, H.; Gertz, B.J.; Fitzgerald, G.A. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J. Pharmacol. Exp. Ther. 1999, 289, 735-741.
7. Swan, S.K.; Rudy, D.W.; Lasseter, K.C.; Ryan, C.F.; Buechel, K.L.; Lambrecht, L.J.; Pinto, M.B.; Dilzer, S.C.; Obrda, O.; Sundblad, K.J.; Gumbs, C.P.; Ebel, D.L.; Quan, H.; Larson, P.J.; Schwartz, J.I.; Musliner, T.A.; Gertz, B.J.; Brater, D.C.; Yao, S.L. Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial. Annu. Intern. Med. 2000, 133, 1-9.
8. Whelton, A.; Maurath, C.J.; Verburg, K.M.; Geis, G.S. Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor. Am. J. Ther. 2000, 7, 159-175.
9. Chan, F.K.; Hung, L.C.; Suen, B.Y.; Wu, J.C.; Lee, K.C.; Leung, V.K.; Hui, A.J.; To, K.F.; Leung, W.K.; Wong, V.W.; Chung, S.C.; Sung, J.J. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. N. Engl. J. Med. 2002, 347, 2104-2110.
10. Markowitz, G.S.; Appel G.B.; Fine, P.L.; Fenves, A.Z.; Loon, N.R.; Jagannath, S.; Kuhn, J.A.; Dratch, A.D.; D'agati, V.D. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J. Am. Soc. Nephrol. 2001, 12, 1164-1172.
11. Markowitz, G.S.; Fine, P.L.; Stack, J.I.; Kunis, C.L.; Radhakrishnan, J.; Palecki, W.; Park, J.; Nasr, S.H.; Hoh, S.; Siegel, D.S.; D'agati, V.D. Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int. 2003, 64, 281-289.
12. De Clercq, E. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin. Microbiol. Rev. 2003, 16, 569-596.
13. Tanji, N.; Tanji, K.; Kambham, N.; Markowitz, G.S.; Bell, A.; D'agati, V.D. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. Human Pathol. 2001, 32, 734-740.
14. Ho, E.S.; Lin, D.C.; Mendel, D.B.; Cihlar, T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J. Am. Soc. Nephrol. 2000, 11, 383-393.
15. Kopp, J.B.; Miller, K.D.; Mican, J.A.; Feuerstein, I.M.; Vaughan, E.; Baker, C.; Pannell, L.K.; Falloon, J. Crystalluria and urinary tract abnormalities associated with indinavir. Annu. Intern. Med. 1997, 127, 119-125.
16. Gagnon, R.F.; Tecimer, S.N.; Watters, A.K.; Tsoukas, C.M. Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir. Am. J. Kidney Dis. 2000, 36, 507-515.
17. Herman, J.S.; Ives, N.J.; Nelson, M.; Gazzard, E.G.; Easterbrook, P.J. Incidence and risk factors for the development of indinavir-associated renal complications. J. Antimicrob. Chemother. 2001, 48, 355-360.
18. Perazella, M.A. Crystal-induced acute renal failure. Am. J. Med. 1999, 106, 459-465.
19. Cayco, A.V.; Perazella, M.A.; Hayslett, J.P. Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature. J. Am. Soc. Nephrol. 1997, 8, 1788-1794.
20. Tsinalis, D.; Dickenmann, M.; Brunner, F.; Gurke, L.; Mihatsch, M.; Nickeleit, V. Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin. Am. J. Kidney Dis. 2002, 40, 667-670.
21. Schortgen, F.; Lacherade, J.C.; Bruneel, F.; Cattaneo, I.; Hemery, F.; Lemaire, F.; Brochard, L. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001, 357, 911-916.
22. De Labarthe, A.; Jacobs, F.; Blot, F.; Glotz, D. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am. J. Med. 2001, 111, 417-418.